- Home
- MRNA vs QRVO Comparison
MRNA vs QRVO Comparison
Compare MRNA & QRVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRNA
- QRVO
- Stock Information
- Founded
- MRNA 2010
- QRVO 1957
- Country
- MRNA United States
- QRVO United States
- Employees
- MRNA N/A
- QRVO N/A
- Industry
- MRNA Biotechnology: Biological Products (No Diagnostic Substances)
- QRVO Semiconductors
- Sector
- MRNA Health Care
- QRVO Technology
- Exchange
- MRNA Nasdaq
- QRVO Nasdaq
- Market Cap
- MRNA 9.8B
- QRVO 8.6B
- IPO Year
- MRNA 2018
- QRVO 1997
- Fundamental
- Price
- MRNA $27.89
- QRVO $91.50
- Analyst Decision
- MRNA Hold
- QRVO Hold
- Analyst Count
- MRNA 17
- QRVO 19
- Target Price
- MRNA $42.40
- QRVO $93.83
- AVG Volume (30 Days)
- MRNA 12.3M
- QRVO 2.1M
- Earning Date
- MRNA 11-06-2025
- QRVO 10-28-2025
- Dividend Yield
- MRNA N/A
- QRVO N/A
- EPS Growth
- MRNA N/A
- QRVO N/A
- EPS
- MRNA N/A
- QRVO 0.85
- Revenue
- MRNA $3,078,000,000.00
- QRVO $3,651,078,000.00
- Revenue This Year
- MRNA N/A
- QRVO $2.23
- Revenue Next Year
- MRNA $9.75
- QRVO $4.34
- P/E Ratio
- MRNA N/A
- QRVO $107.59
- Revenue Growth
- MRNA N/A
- QRVO N/A
- 52 Week Low
- MRNA $23.15
- QRVO $49.46
- 52 Week High
- MRNA $59.73
- QRVO $107.33
- Technical
- Relative Strength Index (RSI)
- MRNA 58.77
- QRVO 46.16
- Support Level
- MRNA $26.91
- QRVO $90.03
- Resistance Level
- MRNA $28.99
- QRVO $95.00
- Average True Range (ATR)
- MRNA 1.22
- QRVO 2.83
- MACD
- MRNA 0.35
- QRVO -0.35
- Stochastic Oscillator
- MRNA 76.78
- QRVO 16.07
About MRNA Moderna Inc.
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 35 mRNA development candidates in clinical studies as of August 2025. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
About QRVO Qorvo Inc.
Qorvo represents the combined entity of RF Micro Devices and TriQuint Semiconductor, which merged in January 2015. The company specializes in radio frequency filters, power amplifiers, and front-end modules used in many of the world's most advanced smartphones. Qorvo also has a suite of products sold into a variety of nonsmartphone end markets, such as wireless base stations, cable TV and networking equipment, and infrastructure and military applications.